Neil Dunavin, MD, MS, discusses ongoing research on therapies for patients with myelofibrosis.
Neil Dunavin, MD, MS
Advertisement
Articles by Neil Dunavin, MD, MS
Neil Dunavin, MD, MS, discusses frontline treatment in myelofibrosis.
Neil Dunavin, MD, MS, assistant professor of medicine, School of Medicine, University of California, San Francisco (UCSF), UCSF Helen Diller Family Comprehensive Cancer Center, discusses treatment considerations in myelofibrosis.
Advertisement
Latest Updated Articles
Dr. Dunavin on Treatment Considerations in MyelofibrosisPublished: January 10th 2020 | Updated:
Dr. Dunavin on Frontline Treatment in MyelofibrosisPublished: January 21st 2020 | Updated:
Dr. Dunavin on Ongoing Research for Myelofibrosis TreatmentsPublished: January 28th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5